IDENTICAL

Identical Brains Studios Share Price

 

 

Start SIP in IDENTICAL

Start SIP

Performance

  • Low
  • ₹25
  • High
  • ₹26
  • 52 Week Low
  • ₹23
  • 52 Week High
  • ₹100
  • Open Price₹25
  • Previous Close₹24
  • Volume20,000

Investment Returns

  • Over 1 Month -31.67%
  • Over 3 Month -38.56%
  • Over 6 Month -46.3%
  • Over 1 Year -54.26%

Smart Investing Starts Here Start SIP with Identical Brains Studios for Steady Growth!

Invest Now

Identical Brains Studios Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 8.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 35
  • P/B Ratio
  • Average True Range
  • 2.17
  • EPS
  • 2.82
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.96
  • RSI
  • 34.9
  • MFI
  • 4.96

Identical Brains Studios Financials

Identical Brains Studios Technicals

EMA & SMA

Current Price
₹24.70
+ 0.6 (2.49%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹28.65
  • 50 Day
  • ₹33.15
  • 100 Day
  • ₹37.09
  • 200 Day
  • ₹43.08

Resistance and Support

25.1 Pivot Speed
  • R3 26.70
  • R2 26.30
  • R1 25.50
  • S1 24.30
  • S2 23.90
  • S3 23.10

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Identical Brains transforms creative ideas into compelling visuals through cutting-edge VFX solutions. With expert supervisors and producers, the team ensures narratives come alive powerfully. They offer seamless storytelling tools, combining imagination with execution to deliver impactful results.

Identical Brains Studios Ltd has an operating revenue of Rs. 55.08 Cr. on a trailing 12-month basis. An annual revenue growth of 27% is outstanding, Pre-tax margin of 21% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 56 indicates it belongs to a fair industry group of Leisure-Movies & Related and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Identical Brains Studios Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-21 Quarterly Results & Others To consider other business matters. (Revised)
2025-09-06 Others To consider other business matters.
2025-05-30 Audited Results & Others To consider other business matters.
2025-05-07 Others To consider other business matters.
2025-03-12 Others To consider 1. Separate Board Meeting of Independent Directors to be held on Wednesday, 12th March,2O25.

Identical Brains Studios F&O

Identical Brains Studios Shareholding Pattern

63.74%
0%
0%
0.03%
0%
29.11%
7.12%

About Identical Brains Studios

  • NSE Symbol
  • IDENTICAL
  • BSE Symbol
  • Managing Director
  • Mr. Raghvendra Rai
  • ISIN
  • INE0TD101011

Similar Stocks to Identical Brains Studios

Identical Brains Studios FAQs

Identical Brains Studios share price is ₹24 As on 12 December, 2025 | 09:32

The Market Cap of Identical Brains Studios is ₹34.6 Cr As on 12 December, 2025 | 09:32

The P/E ratio of Identical Brains Studios is 8.8 As on 12 December, 2025 | 09:32

The PB ratio of Identical Brains Studios is 1 As on 12 December, 2025 | 09:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23